{"cursor":"21827","size":15,"audio":[],"currentlang":"en","article":"\n\n{{Infobox company |company_name = Novo Nordisk A/S |company_logo = |company_type\n= Publicly traded Aktieselskab |traded_as = , |foundation = 1923 |location =\nBagsvÃ¦rd, Denmark |key_people = Sten Scheibye (Chairman) , Lars\nRebien SÃ¸rensen (President and CEO) , Jesper Brandgaard\n(CFO) |industry = Pharmaceuticals, health care |products =\nActivella, Novolin, Levemir, NovoSeven |revenue = DKK 60.8 billion\n(2010) |operating_income = DKK 18.89\nbillion (2010) |net_income = DKK 14.40\nbillion (2010) |assets = DKK 61.40 billion\n(end 2010) |equity = DKK 36.97 billion\n(end 2010) |num_employees = 30,480\n(end 2010) |homepage =\n[http://www.novonordisk.com/ www.novonordisk.com] |intl = yes }}\n\n'Novo Nordisk' manufactures and markets pharmaceutical products and services and\nwas created in 1989 through a merger of two Danish companies dating back to the\n1920s. It produces, in particular, diabetes care equipment and medications. Novo\nNordisk is also involved with haemostasis management, growth hormone therapy and\nhormone replacement therapy. Novo Nordisk is researching pulmonary delivery\nsystems for diabetic medications, and in the early stages of research into\nautoimmune and chronic inflammatory diseases, using technologies such as\ntranslational immunology and monoclonal antibodies \"Biopharmaceutical\nResearch Unit,\" Novo Nordisk Corporation, accessed November 29, 2011,\nhttp://www.novonordisk.com/science/organisation/bru.asp\n\nCompany headquarters are in Denmark, with production facilities in seven\ncountries, and affiliates or offices in 76 countries. It employed approximately\n29,000 people globally as of Q4 2009, and marketed its products in 179\ncountries. It is the largest publicly traded company in the Nordic countries by\nmarket capitalization.\n\nNovo Nordisk is a full member of the European Federation of Pharmaceutical\nIndustries and Associations (EFPIA).\n\nThe company was ranked 25th among 100 best companies to work for in 2010 by For-\ntune. [http://money.cnn.com/magazines/fortune/bestcompanies/2010/full_list/\nMoney.CNN.com] In January 2012, Novo Nordisk was named as the most\nsustainable company in the world by the business magazine Corporate Knights.\n","linknr":392,"url":"Novo_Nordisk","recorded":1364053021,"links":["/w/index.php?title=Novo_Nordisk&action=edit","/w/index.php?title=Novo_Nordisk&action=edit","//en.wikipedia.org/apple-touch-icon.png","//bits.wikimedia.org/favicon/wikipedia.ico","/w/opensearch_desc.php","//en.wikipedia.org/w/api.php?action=rsd","//creativecommons.org/licenses/by-sa/3.0/","/w/index.php?title=Special:RecentChanges&feed=atom","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=ext.gadget.DRN-wizard%2CReferenceTooltips%2Ccharinsert%2Cteahouse%7Cext.wikihiero%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmw.PopUpMediaTransform%7Cskins.vector&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=styles&skin=vector&*","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=startup&only=scripts&skin=vector&*","//bits.wikimedia.org/geoiplookup","//meta.wikimedia.org","#mw-head","#p-search","//upload.wikimedia.org/wikipedia/en/f/f4/Ambox_content.png","/wiki/Wikipedia:NOT#SOAPBOX","//en.wikipedia.org/w/index.php?title=Novo_Nordisk&action=edit","/wiki/Wikipedia:Neutral_point_of_view","/wiki/Wikipedia:EL","//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png","//en.wikipedia.org/w/index.php?title=Novo_Nordisk&action=edit","/wiki/Help:Introduction_to_referencing/1","/wiki/Template:Citation_needed","/wiki/Wikipedia:Verifiability#Burden_of_evidence","/wiki/File:Novo_Nordisk.svg","//upload.wikimedia.org/wikipedia/en/thumb/1/1b/Novo_Nordisk.svg/140px-Novo_Nordisk.svg.png","/wiki/Types_of_business_entity","/wiki/Public_company","/wiki/Aktieselskab","/wiki/Ticker_symbol","/wiki/OMX","http://www.nasdaqomxnordic.com/shares/shareinformation?Instrument=CSE1158","/wiki/New_York_Stock_Exchange","http://www.nyse.com/about/listed/lcddata.html?ticker=nvo","/wiki/Pharmaceuticals","/wiki/Health_care","/wiki/Bagsv%C3%A6rd","/wiki/Denmark","/wiki/Chairman","/wiki/Chief_executive_officer","/wiki/Chief_financial_officer","/wiki/Activella","/wiki/Levemir","/wiki/Danish_krone","#cite_note-AR2010-1","/wiki/Earnings_before_interest_and_taxes","#cite_note-AR2010-1","/wiki/Net_income","#cite_note-AR2010-1","/wiki/Asset","#cite_note-AR2010-1","/wiki/Equity_(finance)","#cite_note-AR2010-1","#cite_note-AR2010-1","http://www.novonordisk.com/","/wiki/Pharmaceutical","/wiki/Diabetes","/wiki/Haemostasis","/wiki/Growth_hormone","/wiki/Hormone_replacement_therapy_(menopause)","#cite_note-2","/wiki/Denmark","/wiki/Nordic_countries","#cite_note-3","/wiki/European_Federation_of_Pharmaceutical_Industries_and_Associations","#cite_note-4","#cite_note-5","/wiki/Corporate_Knights","#Collaborative_research","#Toxicogenomics","#Diabetes","#Additional_research","#Inflammation","#Translational_immunology","#Pharmaceutical_brands","#Levemir","#NovoLog.2FNovoRapid","#NovoLog_Mix_70.2F30","#Novolin_R","#NovoSeven","#Norditropin","#Victoza","#Logo","#Unite_for_Diabetes","#Victoza_controversy","#Transfer_mispricing_controversy","#Timeline","#See_also","#References","#External_links","/w/index.php?title=Novo_Nordisk&action=edit&section=1","/w/index.php?title=Novo_Nordisk&action=edit&section=2","/wiki/Pre-clinical_development","/w/index.php?title=InnoMed_PredTox&action=edit&redlink=1","#cite_note-6","#cite_note-InnoMed_PredTox_official_project_website-7","/wiki/Innovative_Medicines_Initiative","/wiki/EFPIA","/wiki/European_Commission","#cite_note-IMI_Call_Topics_2008-8","/w/index.php?title=Novo_Nordisk&action=edit&section=3","#cite_note-9","/wiki/HIV","/wiki/AIDS","/w/index.php?title=Novo_Nordisk&action=edit&section=4","/w/index.php?title=Novo_Nordisk&action=edit&section=5","#cite_note-10","#cite_note-11","/wiki/Crohn%27s_disease","/wiki/Monoclonal_antibody","/wiki/Natural_killer_cells","#cite_note-12","#cite_note-13","/w/index.php?title=Novo_Nordisk&action=edit&section=6","/wiki/Ex_vivo","#cite_note-14","/wiki/Clinical_trial","#cite_note-15","/w/index.php?title=Novo_Nordisk&action=edit&section=7","/w/index.php?title=Novo_Nordisk&action=edit&section=8","/wiki/Insulin_detemir","/wiki/Levemir","#cite_note-Beals_JM_PM-16","/w/index.php?title=Novo_Nordisk&action=edit&section=9","/wiki/NovoLog","/wiki/Insulin_aspart","#cite_note-Beals_JM_PM-16","/w/index.php?title=Novo_Nordisk&action=edit&section=10","#cite_note-Beals_JM_PM-16","/w/index.php?title=Novo_Nordisk&action=edit&section=11","/w/index.php?title=Novo_Nordisk&action=edit&section=12","/wiki/Recombinant_factor_VII","/wiki/Vitamin_K","/wiki/Hemophilia","#cite_note-17","/w/index.php?title=Novo_Nordisk&action=edit&section=13","/wiki/Somatropin","/w/index.php?title=Novo_Nordisk&action=edit&section=14","/wiki/Liraglutide","/w/index.php?title=Novo_Nordisk&action=edit&section=15","/wiki/Apis_bull","/wiki/Apis_bull","/wiki/Ptah","/wiki/Memphis,_Egypt","/w/index.php?title=Novo_Nordisk&action=edit&section=16","/wiki/International_Diabetes_Federation","/w/index.php?title=Unite_for_Diabetes&action=edit&redlink=1","/wiki/United_Nations","/wiki/World_Diabetes_Day","#cite_note-18","/wiki/Copenhagen","/wiki/Europe","/wiki/Africa","/wiki/Australia","/wiki/Asia","/wiki/Indian_subcontinent","/wiki/United_States","/wiki/New_York_City","/wiki/World_Diabetes_Day","#cite_note-19","/w/index.php?title=Novo_Nordisk&action=edit&section=17","/wiki/Association_of_the_British_Pharmaceutical_Industry","/wiki/Victoza","/wiki/Victoza","#cite_note-20","/w/index.php?title=Novo_Nordisk&action=edit&section=18","/wiki/SKAT_(tax_agency)","#cite_note-21","/w/index.php?title=Novo_Nordisk&action=edit&section=19","/wiki/Hans_Christian_Hagedorn","#cite_note-22","/wiki/NPH_insulin","/wiki/Connaught_Laboratories","/wiki/Recombinant_DNA","/wiki/Steno_Diabetes_Center","/wiki/Repaglinide","/wiki/Christian_Karsten_Hansen","/wiki/Profound_Pharma","/wiki/Maxygen","/wiki/Novorapid","/wiki/Novozymes","/wiki/Levemir","#cite_note-23","/wiki/Greater_Toronto%27s_Top_Employers","/wiki/Toronto_Star","#cite_note-24","#cite_note-25","#cite_note-26","/wiki/Glucagon-like_peptide-1","/wiki/Type_2_diabetes","#cite_note-27","#cite_note-28","#cite_note-29","#cite_note-30","/w/index.php?title=Novo_Nordisk&action=edit&section=20","/wiki/NNIT","/wiki/Repaglinide","/w/index.php?title=Novo_Nordisk&action=edit&section=21","#cite_ref-AR2010_1-0","#cite_ref-AR2010_1-1","#cite_ref-AR2010_1-2","#cite_ref-AR2010_1-3","#cite_ref-AR2010_1-4","#cite_ref-AR2010_1-5","http://annualreport.novonordisk.com/web-media/pdfs/Novo-Nordisk-AR-2010-en.pdf","http://annualreport.novonordisk.com/web-media/pdfs/Novo-Nordisk-AR-2010-en.pdf","#cite_ref-2","http://www.novonordisk.com/science/organisation/bru.asp","#cite_ref-3","http://www.investmenteurope.net/investment-europe/news/2166182/pharma-replaces-oil-biggest-nordic-market-cap-maker","http://www.investmenteurope.net/investment-europe/news/2166182/pharma-replaces-oil-biggest-nordic-market-cap-maker","#cite_ref-4","http://www.efpia.eu/content/default.asp?PageID=559&DocID=4883","#cite_ref-5","http://money.cnn.com/magazines/fortune/bestcompanies/2010/full_list/","#cite_ref-6","/wiki/Methods_in_Molecular_Biology","/wiki/Digital_object_identifier","http://dx.doi.org/10.1007%2F978-1-60327-048-9_11","/wiki/International_Standard_Book_Number","/wiki/Special:BookSources/978-1-58829-638-2","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/18449490","//en.wikipedia.org/w/index.php?title=Template:Cite_doi/10.1007.2F978-1-60327-048-9_11&action=edit&editintro=Template:Cite_doi/editintro2","#cite_ref-InnoMed_PredTox_official_project_website_7-0","http://www.innomed-predtox.com/consortium/members/","http://www.innomed-predtox.com/consortium/members/","#cite_ref-IMI_Call_Topics_2008_8-0","http://imi.europa.eu/docs/calls01_en.zip","http://imi.europa.eu/docs/calls01_en.zip","/wiki/Wikipedia:Link_rot","#cite_ref-9","http://www.worlddiabetesfoundation.org/composite-75.htm","http://www.worlddiabetesfoundation.org/composite-75.htm","#cite_ref-10","http://www.novonordisk.com/science/partnering/inflammation.asp","#cite_ref-11","http://www.levemir.dk/press/news/news.asp?sNewsTypeGUID=&lMonth=0&lYear=2009&sLanguageCode=en-GB&sSearchText=&sShowNewsItemGUID=7947ef3e-9199-4c47-b4eb-ef7c77923429&sShowLanguageCode=en-GB","#cite_ref-12","http://www.novonordisk.com/press/news/news.asp?sNewsTypeGUID=&lMonth=&lYear=&sLanguageCode=&sSearchText=Anti-NKG2D&sShowNewsItemGUID=45cadd39-2d8c-4d42-9db0-ac81d01824cd&sShowLanguageCode=en-GB","#cite_ref-13","http://www.novonordisk.com/science/pipeline/rd_pipeline.asp?showid=9","#cite_ref-14","/wiki/Digital_object_identifier","http://dx.doi.org/10.1186%2F1479-5876-5-59","#cite_ref-15","/wiki/Digital_object_identifier","http://dx.doi.org/10.1111%2Fj.1365-2249.2007.03559.x","#cite_ref-Beals_JM_PM_16-0","#cite_ref-Beals_JM_PM_16-1","#cite_ref-Beals_JM_PM_16-2","#cite_ref-17","#cite_ref-18","http://www.worlddiabetesday.org/news/novo-nordisk-in-united-effort-on-world-diabetes-day","#cite_ref-19","http://diabetesbus.novonordisk.com/Diabetes/Diabetes-Bus/frontpage-default.asp","#cite_ref-20","http://www.pmcpa.org.uk/?q=node/878","#cite_ref-21","http://www.dr.dk/Nyheder/Penge/2013/02/05/112004.htm","#cite_ref-22","/wiki/PubMed_Identifier","//www.ncbi.nlm.nih.gov/pubmed/17877991","#cite_ref-23","http://press.novonordisk-us.com/internal.aspx?rid=325","#cite_ref-24","http://www.eluta.ca/top-employer-novo-nordisk-canada","http://www.eluta.ca/top-employer-novo-nordisk-canada","#cite_ref-25","http://www.cphpost.dk/business/business/45461-ethical-leadership-title-to-novo-companies.html","http://www.cphpost.dk/business/business/45461-ethical-leadership-title-to-novo-companies.html","#cite_ref-26","http://www.justice.gov/opa/pr/2009/May/09-crm-461.html","http://www.justice.gov/opa/pr/2009/May/09-crm-461.html","#cite_ref-27","http://pr-usa.net/index.php?option=com_content&task=view&id=323297&Itemid=96","http://pr-usa.net/index.php?option=com_content&task=view&id=323297&Itemid=96","#cite_ref-28","http://www.bbc.co.uk/news/10189367","#cite_ref-29","http://www.justice.gov/opa/pr/2011/June/11-civ-764.html","http://www.justice.gov/opa/pr/2011/June/11-civ-764.html","#cite_ref-30","http://www.pharmalot.com/2011/03/novo-nordisk-reprimanded-for-poor-management/","http://www.pharmalot.com/2011/03/novo-nordisk-reprimanded-for-poor-management/","/w/index.php?title=Novo_Nordisk&action=edit&section=22","http://www.novonordisk.com","http://www.novo.dk","http://www.novonordiskfonden.dk/","http://www.zenopa.com/news/801274048/Novo_Nordisk_named_world_s_most_sustainable_company","/wiki/Template:OMX_Copenhagen_20_companies","/wiki/Template_talk:OMX_Copenhagen_20_companies","//en.wikipedia.org/w/index.php?title=Template:OMX_Copenhagen_20_companies&action=edit","/wiki/Denmark","//upload.wikimedia.org/wikipedia/commons/thumb/9/9c/Flag_of_Denmark.svg/22px-Flag_of_Denmark.svg.png","/wiki/OMX_Copenhagen_20","/wiki/Denmark","/wiki/Maersk","/wiki/Carlsberg_Group","/wiki/Chr._Hansen","/wiki/Coloplast","/wiki/Danske_Bank","/wiki/DSV_(company)","/wiki/FLSmidth","/wiki/GN_Store_Nord","/wiki/Lundbeck","/wiki/NKT_Holding","/wiki/Nordea","/wiki/Novozymes","/wiki/Pandora_(jewelry)","/wiki/TDC_A/S","/w/index.php?title=Topdanmark&action=edit&redlink=1","/wiki/Tryg","/wiki/Vestas","/wiki/William_Demant","http://en.wikipedia.org/w/index.php?title=Novo_Nordisk&oldid=540636798","/wiki/Help:Categories","/wiki/Category:Companies_listed_on_the_New_York_Stock_Exchange","/wiki/Category:Pharmaceutical_companies_of_Denmark","/wiki/Category:Biotechnology_companies_of_Denmark","/wiki/Category:Life_science_companies_based_in_Copenhagen","/wiki/Category:Companies_based_in_Gladsaxe_Municipality","/wiki/Category:Companies_established_in_1923","/wiki/Category:All_articles_with_dead_external_links","/wiki/Category:Articles_with_dead_external_links_from_September_2010","/wiki/Category:Articles_with_a_promotional_tone_from_November_2011","/wiki/Category:All_articles_with_a_promotional_tone","/wiki/Category:Articles_needing_additional_references_from_August_2008","/wiki/Category:All_articles_needing_additional_references","/w/index.php?title=Special:UserLogin&returnto=Novo+Nordisk&type=signup","/w/index.php?title=Special:UserLogin&returnto=Novo+Nordisk","/wiki/Novo_Nordisk","/wiki/Talk:Novo_Nordisk","#","/wiki/Novo_Nordisk","/w/index.php?title=Novo_Nordisk&action=edit","/w/index.php?title=Novo_Nordisk&action=history","#","/w/index.php","//bits.wikimedia.org/static-1.21wmf11/skins/vector/images/search-ltr.png?303-4","/wiki/Main_Page","/wiki/Main_Page","/wiki/Portal:Contents","/wiki/Portal:Featured_content","/wiki/Portal:Current_events","/wiki/Special:Random","//donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&utm_medium=sidebar&utm_campaign=C13_en.wikipedia.org&uselang=en","/wiki/Help:Contents","/wiki/Wikipedia:About","/wiki/Wikipedia:Community_portal","/wiki/Special:RecentChanges","/wiki/Wikipedia:Contact_us","/wiki/Special:WhatLinksHere/Novo_Nordisk","/wiki/Special:RecentChangesLinked/Novo_Nordisk","/wiki/Wikipedia:File_Upload_Wizard","/wiki/Special:SpecialPages","/w/index.php?title=Novo_Nordisk&oldid=540636798","/w/index.php?title=Novo_Nordisk&action=info","/w/index.php?title=Special:Cite&page=Novo_Nordisk&id=540636798","/w/index.php?title=Special:Book&bookcmd=book_creator&referer=Novo+Nordisk","/w/index.php?title=Special:Book&bookcmd=render_article&arttitle=Novo+Nordisk&oldid=540636798&writer=rl","/w/index.php?title=Novo_Nordisk&printable=yes","//bg.wikipedia.org/wiki/%D0%9D%D0%BE%D0%B2%D0%BE_%D0%9D%D0%BE%D1%80%D0%B4%D0%B8%D1%81%D0%BA","//da.wikipedia.org/wiki/Novo_Nordisk","//de.wikipedia.org/wiki/Novo_Nordisk","//es.wikipedia.org/wiki/Novo_Nordisk","//fr.wikipedia.org/wiki/Novo_Nordisk","//it.wikipedia.org/wiki/Novo_Nordisk","//nl.wikipedia.org/wiki/Novo_Nordisk","//ja.wikipedia.org/wiki/%E3%83%8E%E3%83%9C%E3%83%8E%E3%83%AB%E3%83%87%E3%82%A3%E3%82%B9%E3%82%AF","//no.wikipedia.org/wiki/Novo_Nordisk","//pt.wikipedia.org/wiki/Novo_Nordisk","//ro.wikipedia.org/wiki/Novo_Nordisk","//ru.wikipedia.org/wiki/Novo_Nordisk","//zh.wikipedia.org/wiki/%E8%AF%BA%E5%92%8C%E8%AF%BA%E5%BE%B7","//www.wikidata.org/wiki/Special:ItemByTitle/enwiki/Novo Nordisk","//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License","//creativecommons.org/licenses/by-sa/3.0/","//wikimediafoundation.org/wiki/Terms_of_Use","//www.wikimediafoundation.org/","//en.wikipedia.org/wiki/Wikipedia:Contact_us","//wikimediafoundation.org/wiki/Privacy_policy","/wiki/Wikipedia:About","/wiki/Wikipedia:General_disclaimer","http://en.m.wikipedia.org/wiki/Novo_Nordisk","//wikimediafoundation.org/","//bits.wikimedia.org/images/wikimedia-button.png","//www.mediawiki.org/","//bits.wikimedia.org/static-1.21wmf11/skins/common/images/poweredby_mediawiki_88x31.png","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=skins.vector&only=scripts&skin=vector&*","/w/index.php?title=MediaWiki:Gadget-ReferenceTooltips.js&action=raw&ctype=text/javascript&508635914","//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&lang=en&modules=site&only=scripts&skin=vector&*"],"instances":["menopause","tax_agency"],"pdf":["http://annualreport.novonordisk.com/web-media/pdfs/Novo-Nordisk-AR-2010-en.pdf","http://annualreport.novonordisk.com/web-media/pdfs/Novo-Nordisk-AR-2010-en.pdf"],"categories":["Companies listed on the New York Stock Exchange","Pharmaceutical companies of Denmark","Biotechnology companies of Denmark","Life science companies based in Copenhagen","Companies based in Gladsaxe Municipality","Companies established in 1923"],"headings":["Collaborative research","Additional research","Pharmaceutical brands","Logo","Unite for Diabetes","Victoza controversy","Transfer mispricing controversy","Timeline","See also","References","External links"],"image":["//upload.wikimedia.org/wikipedia/en/f/f4/Ambox_content.png","//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png","//upload.wikimedia.org/wikipedia/en/thumb/1/1b/Novo_Nordisk.svg/140px-Novo_Nordisk.svg.png","//upload.wikimedia.org/wikipedia/commons/thumb/9/9c/Flag_of_Denmark.svg/22px-Flag_of_Denmark.svg.png","//bits.wikimedia.org/static-1.21wmf11/skins/vector/images/search-ltr.png?303-4","//bits.wikimedia.org/images/wikimedia-button.png","//bits.wikimedia.org/static-1.21wmf11/skins/common/images/poweredby_mediawiki_88x31.png"],"tags":[["hormone_replacement_therapy","menopause"],["skat","tax_agency"]],"members":["hormone_replacement_therapy","skat"],"related":["Public_company","Aktieselskab","Bagsværd","Denmark","Chairman","Chief_executive_officer","Chief_financial_officer","Pharmaceuticals","Health_care","Activella","Levemir","Danish_krone","Pharmaceutical","Diabetes","Haemostasis","Growth_hormone","Hormone_replacement_therapy_(menopause)","Denmark","Nordic_countries","European_Federation_of_Pharmaceutical_Industries_and_Associations","Corporate_Knights","Pre-clinical_development","InnoMed_PredTox","Innovative_Medicines_Initiative","EFPIA","European_Commission","HIV","AIDS","Crohn's_disease","Monoclonal_antibody","Natural_killer_cells","Ex_vivo","Clinical_trial","Levemir","NovoLog","Insulin_aspart","Recombinant_factor_VII","Vitamin_K","Hemophilia","Somatropin","Apis_bull","Apis_bull","Ptah","Memphis,_Egypt","International_Diabetes_Federation","Unite_for_Diabetes","United_Nations","World_Diabetes_Day","Copenhagen","Europe","Africa","Australia","Asia","Indian_subcontinent","United_States","New_York_City","World_Diabetes_Day","Association_of_the_British_Pharmaceutical_Industry","Victoza","Victoza","SKAT_(tax_agency)","Hans_Christian_Hagedorn","NPH_insulin","Recombinant_DNA","Steno_Diabetes_Center","Repaglinide","Christian_Karsten_Hansen","Profound_Pharma","Maxygen","Novorapid","Novozymes","Levemir","Greater_Toronto's_Top_Employers","Toronto_Star","Glucagon-like_peptide-1","Type_2_diabetes","NNIT","Repaglinide"]}